<!doctype html><html lang="en-US"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1"><title>Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science</title><link rel="preload" href="../../assets/images/branding/logo.png" as="image" /><link rel="preload" href="../../assets/images/branding/logo-dark.png" as="image" /><link rel="stylesheet" href="../../assets/css/vendor/normalize.css"><link rel="stylesheet" href="../../assets/css/variables.css"><link rel="stylesheet" href="../../assets/css/site-layout.css"><link rel="stylesheet" href="../../assets/css/article-content.css"><link rel="stylesheet" href="../../assets/css/print.css"><meta name="robots" content="noarchive"><link rel="apple-touch-icon" sizes="180x180" href="../../apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="../../favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="../../favicon-16x16.png"><link rel="icon" href="../../favicon.ico"><link rel="manifest" href="../../site.webmanifest"><meta name="msapplication-TileColor" content="#ece5ff"><meta name="theme-color" content="#ffffff"><link type="application/atom+xml" rel="alternate" href="../../feed-posts.xml" title="Transfeminine Science" /><link rel="alternate" type="application/atom+xml" title="Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science" href="../../feed.xml"><link rel="canonical" href="index.html" /><meta property="og:title" content="Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy" /><meta property="og:image" content="https://transfemscience.org/assets/images/branding/logo-alt.png" /><meta name="twitter:image" content="https://transfemscience.org/assets/images/branding/logo-alt.png" /><meta property="og:url" content="https://transfemscience.org/articles/shbg-unimportant-suppl/" /><meta property="og:locale" content="en_US" /><meta property="og:site_name" content="Transfeminine Science" /><meta property="og:type" content="article" /><meta name="twitter:card" content="summary" /><meta name="publisher" content="Transfeminine Science"><meta name="description" content="Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy by Aly" /><meta property="og:description" content="Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy by Aly" /><meta name="author" content="Aly" /><meta name="citation_author" content="Aly"><meta name="citation_title" content="Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy"><meta name="citation_publication_date" content="2020/07/08"><meta name="citation_journal_title" content="Transfeminine Science"><meta name="citation_fulltext_html_url" content="https://transfemscience.org/articles/shbg-unimportant-suppl/"> <script type="application/ld+json"> { "@context": "https://schema.org", "name": "Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy", "mainEntityOfPage": "https://transfemscience.org/articles/shbg-unimportant-suppl/", "headline": "Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy", "url": "https://transfemscience.org/articles/shbg-unimportant-suppl/", "isAccessibleForFree": "True", "description": "Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy by Aly", "@type": "MedicalScholarlyArticle", "dateModified": "2023-03-14", "datePublished": "2020-07-08", "author": { "@type": "Person", "name": "Aly", "email": "", "url": "https://transfemscience.org/about/#aly" }, "publisher": { "@type": "Organization", "name": "Transfeminine Science", "url": "https://transfemscience.org", "email": "info@transfemscience.org", "logo": "https://transfemscience.org/assets/images/branding/logo.png" } } </script><script type="application/ld+json"> { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://transfemscience.org/" }, { "@type": "ListItem", "position": 2, "name": "Articles", "item": "https://transfemscience.org/articles/" }, { "@type": "ListItem", "position": 3, "name": "Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy" } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://transfemscience.org/" }, { "@type": "ListItem", "position": 2, "name": "Articles", "item": "https://transfemscience.org/articles/" }, { "@type": "ListItem", "position": 3, "name": "Articles by Date", "item": "https://transfemscience.org/articles-by-date/" }, { "@type": "ListItem", "position": 4, "name": "Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy" } ] } </script> <script src="../../assets/js/script.js"></script></head><body> <svg xmlns="http://www.w3.org/2000/svg" style="display: none;"> <symbol id="svg-link" viewBox="0 0 24 24"><title>Link</title><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="feather feather-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path> </svg> </symbol> </svg><div id="header"><div id="header-subcontainer"> <a href="../../index.html" id="site-icon-and-title-container"> <span id="site-icon">&nbsp;</span> <span id="site-title" translate="no" class="notranslate"> <span id="site-title-text-xs">TFS</span> <span id="site-title-text-sm">TFSci</span> <span id="site-title-text-md">Transfem Sci</span> <span id="site-title-text-lg">Transfeminine Science</span> </span> </a> <span id="top-links"> <a href="../index.html" class="top-link">Articles</a> <a href="../../articles-by-date/index.html" class="top-link">Latest</a> <a href="../../misc/index.html" class="top-link">Misc</a> <a href="../../about/index.html" class="top-link">About</a> </span> <span id="top-buttons"> <button id="theme-button" class="top-button" title="Theme (light/dark)"> <svg id="theme-button-light-svg" class="top-button-svg" width="20" height="20" viewBox="0 0 32 32"><path d="M16 12.005a4 4 0 1 1-4 4a4.005 4.005 0 0 1 4-4m0-2a6 6 0 1 0 6 6a6 6 0 0 0-6-6z"></path><path d="M5.394 6.813l1.414-1.415l3.506 3.506L8.9 10.318z"></path><path d="M2 15.005h5v2H2z"></path><path d="M5.394 25.197L8.9 21.691l1.414 1.415l-3.506 3.505z"></path><path d="M15 25.005h2v5h-2z"></path><path d="M21.687 23.106l1.414-1.415l3.506 3.506l-1.414 1.414z"></path><path d="M25 15.005h5v2h-5z"></path><path d="M21.687 8.904l3.506-3.506l1.414 1.415l-3.506 3.505z"></path><path d="M15 2.005h2v5h-2z"></path></svg> <svg id="theme-button-dark-svg" class="top-button-svg" width="20" height="20" viewBox="0 0 32 32"><path d="M13.502 5.414a15.075 15.075 0 0 0 11.594 18.194a11.113 11.113 0 0 1-7.975 3.39c-.138 0-.278.005-.418 0a11.094 11.094 0 0 1-3.2-21.584M14.98 3a1.002 1.002 0 0 0-.175.016a13.096 13.096 0 0 0 1.825 25.981c.164.006.328 0 .49 0a13.072 13.072 0 0 0 10.703-5.555a1.01 1.01 0 0 0-.783-1.565A13.08 13.08 0 0 1 15.89 4.38A1.015 1.015 0 0 0 14.98 3z"></path></svg> </button> <button id="language-button" class="top-button" title="Translate"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24"><path d="M12.65 15.67c.14-.36.05-.77-.23-1.05l-2.09-2.06.03-.03c1.74-1.94 2.98-4.17 3.71-6.53h1.94c.54.0.99-.45.99-.99v-.02c0-.54-.45-.99-.99-.99H10V3c0-.55-.45-1-1-1s-1 .45-1 1v1H1.99c-.54.0-.99.45-.99.99.0.55.45.99.99.99h10.18C11.5 7.92 10.44 9.75 9 11.35c-.81-.89-1.49-1.86-2.06-2.88-.16-.29-.45-.47-.78-.47-.69.0-1.13.75-.79 1.35.63 1.13 1.4 2.21 2.3 3.21L3.3 16.87c-.4.39-.4 1.03.0 1.42.39.39 1.02.39 1.42.0L9 14l2.02 2.02c.51.51 1.38.32 1.63-.35zM17.5 10c-.6.0-1.14.37-1.35.94l-3.67 9.8c-.24.61.22 1.26.87 1.26.39.0.74-.24.88-.61l.89-2.39h4.75l.9 2.39c.14.36.49.61.88.61.65.0 1.11-.65.88-1.26l-3.67-9.8c-.22-.57-.76-.94-1.36-.94zm-1.62 7 1.62-4.33L19.12 17h-3.24z"></path></svg> </button> <button id="search-button" class="top-button" title="Search"> <svg version="1.1" class="top-button-svg" width="24" height="24" viewBox="0 0 32 32" xmlns="http://www.w3.org/2000/svg" xmlns:sketch="http://www.bohemiancoding.com/sketch/ns" xmlns:xlink="http://www.w3.org/1999/xlink"><g><path d="M19.4271164,21.4271164 C18.0372495,22.4174803 16.3366522,23 14.5,23 C9.80557939,23 6,19.1944206 6,14.5 C6,9.80557939 9.80557939,6 14.5,6 C19.1944206,6 23,9.80557939 23,14.5 C23,16.3366522 22.4174803,18.0372495 21.4271164,19.4271164 L27.0119176,25.0119176 C27.5621186,25.5621186 27.5575313,26.4424687 27.0117185,26.9882815 L26.9882815,27.0117185 C26.4438648,27.5561352 25.5576204,27.5576204 25.0119176,27.0119176 L19.4271164,21.4271164 L19.4271164,21.4271164 Z M14.5,21 C18.0898511,21 21,18.0898511 21,14.5 C21,10.9101489 18.0898511,8 14.5,8 C10.9101489,8 8,10.9101489 8,14.5 C8,18.0898511 10.9101489,21 14.5,21 L14.5,21 Z"></path></g></svg> </button> <button id="toc-button-mobile" class="top-button" title="Article contents (Ctrl+Shift+L)"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </button> <button id="menu-button-mobile-menu" class="top-button" title="Menu"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" width="21" height="21" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"><path d="M 3,12 L 21,12" /><path d="M 3,6 L 21,6" /><path d="M 3,18 L 21,18" /></svg> </button> <button id="hide-persistent-header-button" class="top-button" title="Hide top bar (Ctrl+Shift+H)"> <svg id="hide-persistent-header-button-svg" version="1.1" x="0px" y="0px" width="20px" height="20px" viewBox="0 0 24 24" enable-background="new 0 0 24 24" xml:space="preserve" fill="#5F6368"><path d="M8.59,16.59L13.17,12L8.59,7.41L10,6l6,6l-6,6L8.59,16.59z"></path><path fill="none" d="M0,0h24v24H0V0z"></path></svg> </button> </span></div><div id="mobile-menu"> <span id="top-links-mobile"> <a href="../index.html" class="top-link">Articles</a> <a href="../../articles-by-date/index.html" class="top-link">Latest</a> <a href="../../misc/index.html" class="top-link">Misc</a> <a href="../../about/index.html" class="top-link">About</a> </span></div></div><button id="restore-persistent-header-button" class="top-button" title="Show top bar (Ctrl+Shift+H)"> <svg id="restore-persistent-header-button-svg" version="1.1" x="0px" y="0px" width="20px" height="20px" viewBox="0 0 24 24" enable-background="new 0 0 24 24" xml:space="preserve" fill="#5F6368"><path d="M8.59,16.59L13.17,12L8.59,7.41L10,6l6,6l-6,6L8.59,16.59z"></path><path fill="none" d="M0,0h24v24H0V0z"></path></svg> </button> <button id="sidebar-button-standalone" class="sidebar-button" title="Article contents (Ctrl+Shift+L)"> <span id="sidebar-button-standalone-icon" class="sidebar-button-icon"> <svg id="sidebar-button-standalone-icon-svg" class="sidebar-button-icon-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </span> </button><div id="mid-section"><div id="sidebar"><div id="sidebar-subcontainer"><div id="sidebar-title-container"> <button id="sidebar-button" class="sidebar-button" title="Article contents (Ctrl+Shift+L)"> <span class="sidebar-button-icon"> <svg class="sidebar-button-icon-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </span> </button> <span id="sidebar-title">Contents</span></div><div id="sidebar-contents"><div class="toc-h1"><a id="heading-0" href="index.html#top" class="toc-link">Top of page</a><div><div class="toc-h2"><a id="heading-1" href="index.html#preface" class="toc-link">Preface</a></div><div class="toc-h2"><a id="heading-2" href="index.html#calculation-of-free-hormone-levels" class="toc-link">Calculation of Free Hormone Levels</a><div><div class="toc-h3"><a id="heading-3" href="index.html#spreadsheet-calculator-mazer-2009" class="toc-link">Spreadsheet Calculator (Mazer, 2009)</a><div><div class="toc-h4"><a id="heading-4" href="index.html#some-experimentation-with-the-calculator" class="toc-link">Some Experimentation with the Calculator</a></div></div></div><div class="toc-h3"><a id="heading-5" href="index.html#other-papers-on-calculation-of-free-hormone-levels" class="toc-link">Other Papers on Calculation of Free Hormone Levels</a></div><div class="toc-h3"><a id="heading-6" href="index.html#other-online-free-hormone-calculators" class="toc-link">Other Online Free Hormone Calculators</a></div></div></div><div class="toc-h2"><a id="heading-7" href="index.html#additional-literature-on-shbg-and-free-estradiol" class="toc-link">Additional Literature on SHBG and Free Estradiol</a><div><div class="toc-h3"><a id="heading-8" href="index.html#additional-shbg-and-free-estradiol-clinical-studies" class="toc-link">Additional SHBG and Free Estradiol Clinical Studies</a></div><div class="toc-h3"><a id="heading-9" href="index.html#miscellaneous" class="toc-link">Miscellaneous</a></div></div></div><div class="toc-h2"><a id="heading-10" href="index.html#references" class="toc-link">References</a></div></div></div></div></div></div><div id="main-area"><div id="article"><h1 id="supplement-the-interactions-of-sex-hormones-with-sex-hormone-binding-globulin-and-relevance-for-transfeminine-hormone-therapy"> <a href="index.html#supplement-the-interactions-of-sex-hormones-with-sex-hormone-binding-globulin-and-relevance-for-transfeminine-hormone-therapy" aria-labelledby="supplement-the-interactions-of-sex-hormones-with-sex-hormone-binding-globulin-and-relevance-for-transfeminine-hormone-therapy" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy</h1><p>By <a href="../../about/index.html#aly">Aly</a> | First published July 8, 2020 | Last modified March 14, 2023</p><h2 id="preface"> <a href="index.html#preface" aria-labelledby="preface" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Preface</h2><p>This article is a supplement to the article <a href="../shbg-unimportant/index.html">here</a>. It was originally just for calculation of free sex hormone levels but I decided to add some other content to it as well.</p><h2 id="calculation-of-free-hormone-levels"> <a href="index.html#calculation-of-free-hormone-levels" aria-labelledby="calculation-of-free-hormone-levels" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Calculation of Free Hormone Levels</h2><h3 id="spreadsheet-calculator-mazer-2009"> <a href="index.html#spreadsheet-calculator-mazer-2009" aria-labelledby="spreadsheet-calculator-mazer-2009" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Spreadsheet Calculator (Mazer, 2009)</h3><p>A researcher developed and published a “user-friendly” spreadsheet that can be used to calculate free and bioavailable levels of several steroid hormones (<a href="https://doi.org/10.1016/j.steroids.2009.01.008">Mazer, 2009</a>). This spreadsheet approach is analogous to how free hormone levels are calculated with actual conventional blood work. Total hormone levels and levels of plasma proteins like albumin and SHBG are taken as inputs by the spreadsheet, and free and bioavailable hormone levels are given as outputs.</p><p>The spreadsheet is supplementary material for <a href="https://doi.org/10.1016/j.steroids.2009.01.008">Mazer (2009)</a> and is behind a paywall. Because of this, I’ve uploaded a copy of the original spreadsheet <a href="../../../files.transfemscience.org/pdfs/misc/Mazer&#32;(2009)&#32;-&#32;Free&#32;Bioavailable&#32;Hormone&#32;Calculator.xls">here</a> (Microsoft Excel or XLS format).</p><p>If you’re curious how SHBG may be influencing your free estradiol percentage, you can use the spreadsheet to get an estimate. If you don’t have albumin, CBG, or cortisol values, you can use the default input values in the spreadsheet. If you don’t have other input values (e.g., estrone or SHBG), you can input representative values that are sensible for your scenario. It should be noted that calculated free hormone levels are only estimates and hence can be inaccurate. In any case, they are generally fairly close to the values that would be obtained with actual measurement. Use of default input values as opposed to real measured numbers may further contribute to inaccuracy.</p><h4 id="some-experimentation-with-the-calculator"> <a href="index.html#some-experimentation-with-the-calculator" aria-labelledby="some-experimentation-with-the-calculator" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Some Experimentation with the Calculator</h4><p>Here are the results of some experimentation I did with the calculator:</p><p><strong>Table:</strong> Relationships between SHBG levels and calculated free estradiol fraction at fixed estradiol levels:</p><htmlprotect><div class="table-wrapper"><table><thead><tr><th colspan="2"><b>SHBG</b></th><th colspan="2"><b>Estradiol fixed ≤1,000 pg/mL</b></th><th colspan="2"><b>Estradiol fixed 20,000 pg/mL</b></th></tr><tr><th><b>Level</b></th><th><b>Change <sup>a</sup></b></th><th><b>Free E2 fraction</b></th><th><b>Change <sup>a</sup></b></th><th><b>Free E2 fraction</b></th><th><b>Change <sup>a</sup></b></th></tr></thead><tbody><tr><td>0 nmol/L</td><td>0.0×</td><td>3.26%</td><td>+77.2%</td><td>3.26%</td><td>+37.0%</td></tr><tr><td>25 nmol/L</td><td>0.5×</td><td>2.36%</td><td>+28.3%</td><td>2.78%</td><td>+16.8%</td></tr><tr><td>50 nmol/L</td><td>1.0×</td><td>1.84%</td><td>0%</td><td>2.38%</td><td>0%</td></tr><tr><td>75 nmol/L</td><td>1.5×</td><td>1.50%</td><td>–18.5%</td><td>2.04%</td><td>–14.3%</td></tr><tr><td>100 nmol/L</td><td>2.0×</td><td>1.27%</td><td>–31.0%</td><td>1.77%</td><td>–25.6%</td></tr><tr><td>125 nmol/L</td><td>2.5×</td><td>1.10%</td><td>–40.2%</td><td>1.54%</td><td>–35.3%</td></tr><tr><td>150 nmol/L</td><td>3.0×</td><td>0.97%</td><td>–47.3%</td><td>1.36%</td><td>–42.9%</td></tr><tr><td>200 nmol/L</td><td>4.0×</td><td>0.79%</td><td>–57.1%</td><td>1.08%</td><td>–54.6%</td></tr><tr><td>250 nmol/L</td><td>5.0×</td><td>0.66%</td><td>–64.1%</td><td>0.89%</td><td>–62.6%</td></tr><tr><td>300 nmol/L</td><td>6.0×</td><td>0.57%</td><td>–69.0%</td><td>0.75%</td><td>–68.5%</td></tr><tr><td>350 nmol/L</td><td>7.0×</td><td>0.50%</td><td>–72.8%</td><td>0.65%</td><td>–72.7%</td></tr><tr><td>400 nmol/L</td><td>8.0×</td><td>0.44%</td><td>–76.1%</td><td>0.57%</td><td>–76.1%</td></tr></tbody></table></div></htmlprotect><p><sup>a</sup> Change relative to a reasonable non-pregnancy physiological value (specifically 50 nmol/L for SHBG, 1.84% for free E2 at a fixed level of ≤1,000 pg/mL, 2.38% for free E2 at a fixed level of 20,000 pg/mL).</p><p>Androgen levels were set to female levels, estrone levels were set to be the same as estradiol levels, and all other inputs besides SHBG and total estradiol levels were left as the defaults. There was very little variation in free estradiol fractions with different estradiol levels at and below 1,000 pg/mL for each given level of SHBG (hence why the table says “Estradiol fixed ≤1,000 pg/mL”).</p><p>The estradiol levels fixed to ≤1,000 pg/mL are intended to represent typical therapeutic circumstances while the estradiol levels fixed to 20,000 pg/mL are supposed to represent late pregnancy.</p><p>Note that since estradiol induces SHBG production, SHBG levels are strongly correlated with estradiol levels. Generally speaking, when estradiol is low, SHBG will also be low, and when estradiol is high, SHBG will also be high. Hence, having highly divergent SHBG and estradiol levels as in the table would be very unusual and is physiologically unrealistic. It is only explored here as a thought experiment.</p><p>Note again that these free estradiol numbers are calculated and hence are only estimates.</p><h3 id="other-papers-on-calculation-of-free-hormone-levels"> <a href="index.html#other-papers-on-calculation-of-free-hormone-levels" aria-labelledby="other-papers-on-calculation-of-free-hormone-levels" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Other Papers on Calculation of Free Hormone Levels</h3><p>Aside from <a href="https://doi.org/10.1016/j.steroids.2009.01.008">Mazer (2009)</a>, other papers like <a href="https://doi.org/10.1210/jcem.84.10.6079">Vermeulen, Verdonck, &amp; Kaufman (1999)</a> and <a href="https://cebp.aacrjournals.org/content/11/10/1065.short">Rinaldi et al. (2002)</a> also discuss calculation of free sex hormone levels and the validity of this approach.</p><h3 id="other-online-free-hormone-calculators"> <a href="index.html#other-online-free-hormone-calculators" aria-labelledby="other-online-free-hormone-calculators" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Other Online Free Hormone Calculators</h3><p>Another tool for calculating free estradiol and testosterone can be found <a href="https://diyhrt.cafe/free-e2-estimator/">here</a>. Various other free testosterone calculators also exist on the web (<a href="https://www.google.com/search?q=free+testosterone+calculator">Google Search</a>).</p><h2 id="additional-literature-on-shbg-and-free-estradiol"> <a href="index.html#additional-literature-on-shbg-and-free-estradiol" aria-labelledby="additional-literature-on-shbg-and-free-estradiol" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Additional Literature on SHBG and Free Estradiol</h2><h3 id="additional-shbg-and-free-estradiol-clinical-studies"> <a href="index.html#additional-shbg-and-free-estradiol-clinical-studies" aria-labelledby="additional-shbg-and-free-estradiol-clinical-studies" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Additional SHBG and Free Estradiol Clinical Studies</h3><p>Some more good studies on SHBG and free estradiol that weren’t discussed in the main article:</p><ul><li><a href="https://doi.org/10.1530/acta.0.1010248">Odlind et al. (1982)</a> – various forms of estrogen on SHBG in cis women</li><li><a href="https://doi.org/10.1016/S0015-0282(16)49633-0">Ben-Rafael et al. (1986)</a> [<a href="https://archive.is/lXeD9">Table</a>] – gonadotropin stimulation in cis women</li><li><a href="https://doi.org/10.1016/0378-5122(88)90066-7">Carlström, Pschera, &amp; Lunell (1986)</a> [<a href="https://archive.is/584c1">Excerpt</a>] – vaginal estradiol in cis women + review</li><li><a href="https://doi.org/10.1016/0378-5122(88)90062-X">Jasonni et al. (1988)</a> [<a href="https://archive.is/DR81U">Excerpt</a>] – transdermal estradiol in cis women + review</li><li><a href="https://doi.org/10.1530/EJE-07-0511">Elaut et al. (2008)</a> [<a href="https://archive.is/7gF49">Table</a>] – various estrogens in transfeminine people</li><li><a href="https://doi.org/10.1016/j.bone.2008.09.001">Lapauw et al. (2008)</a> [<a href="https://archive.is/4pEEk">Table</a>] – various estrogens in transfeminine people</li><li><a href="https://doi.org/10.1089/trgh.2016.0016">Nelson et al. (2016)</a> [<a href="https://archive.is/MlUU5">Table</a>] – mainly high-dose injectable estradiol in transfeminine people</li></ul><h3 id="miscellaneous"> <a href="index.html#miscellaneous" aria-labelledby="miscellaneous" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Miscellaneous</h3><p>A case report of a young woman with <a href="https://en.wikipedia.org/wiki/Estrogen_insensitivity_syndrome">estrogen insensitivity syndrome</a> (EIS) (i.e., defective ERα) suggests that the <a href="https://en.wikipedia.org/wiki/Estrogen_receptor_alpha">ERα</a> is the specific <a href="https://en.wikipedia.org/wiki/Estrogen_receptor">estrogen receptor</a> that is responsible for increased SHBG production and levels with estrogens (<a href="http://doi.org/10.1056/NEJMoa1303611">Quaynor et al., 2013</a>). Due to her EIS and lack of negative feedback on the hypothalamus–pituitary–gonadal axis, the woman had estradiol levels of as high as 3,500 pg/mL. In spite of this however, her SHBG levels remained less than 50 nmol/L. During pregnancy, at the point in the second trimester at which estradiol levels reach 3,000 pg/mL, SHBG levels are normally around 300 nmol/L on average (a 6-fold increase from a pre-pregnancy baseline of about 50 nmol/L).</p><h2 id="references"> <a href="index.html#references" aria-labelledby="references" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> References</h2><ul><li>Ben-Rafael, Z., Mastroianni, L., Meloni, F., Strauss, J. F., &amp; Flickinger, G. L. (1986). Changes in serum sex hormone-binding globulin, free estradiol, and testosterone during gonadotropin treatment. <em>Fertility and Sterility</em>, <em>46</em>(4), 593–598. [DOI:<a href="https://doi.org/10.1016/s0015-0282(16)49633-0">10.1016/s0015-0282(16)49633-0</a>]</li><li>Carlström, K., Pschera, H., &amp; Lunell, N. (1988). Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17β-oestradiol and progesterone in the pre- and post-menopause. <em>Maturitas</em>, <em>10</em>(4), 307–316. [DOI:<a href="https://doi.org/10.1016/0378-5122(88)90066-7">10.1016/0378-5122(88)90066-7</a>]</li><li>Elaut, E., De Cuypere, G., De Sutter, P., Gijs, L., Van Trotsenburg, M., Heylens, G., Kaufman, J., Rubens, R., &amp; T’Sjoen, G. (2008). Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels. <em>European Journal of Endocrinology</em>, <em>158</em>(3), 393–399. [DOI:<a href="https://doi.org/10.1530/eje-07-0511">10.1530/eje-07-0511</a>]</li><li>Jasonni, V., Bulletti, C., Naldi, S., Ciotti, P., Di Cosmo, D., Lazzaretto, R., &amp; Flamigni, C. (1988). Biological and endocrine aspects of transdermal 17β-oestradiol administration in post-menopausal women. <em>Maturitas</em>, <em>10</em>(4), 263–270. [DOI:<a href="https://doi.org/10.1016/0378-5122(88)90062-x">10.1016/0378-5122(88)90062-x</a>]</li><li>Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J., &amp; T’Sjoen, G. G. (2008). Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. <em>Bone</em>, <em>43</em>(6), 1016–1021. [DOI:<a href="https://doi.org/10.1016/j.bone.2008.09.001">10.1016/j.bone.2008.09.001</a>]</li><li>Mazer, N. A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. <em>Steroids</em>, <em>74</em>(6), 512–519. [DOI:<a href="https://doi.org/10.1016/j.steroids.2009.01.008">10.1016/j.steroids.2009.01.008</a>]</li><li>Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., &amp; Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? <em>Transgender Health</em>, <em>1</em>(1), 165–171. [DOI:<a href="https://doi.org/10.1089/trgh.2016.0016">10.1089/trgh.2016.0016</a>]</li><li>Odlind, V., Elamsson, K., Englund, D. E., Victor, A., &amp; Johansson, E. D. (1982). Effects of oestradiol on sex hormone binding globulin. <em>Acta Endocrinologica</em>, <em>101</em>(2), 248–253. [DOI:<a href="https://doi.org/10.1530/acta.0.1010248">10.1530/acta.0.1010248</a>] [<a href="https://web.archive.org/web/20190219195439/https://pdfs.semanticscholar.org/1db8/6cdc77c182def190c67cf37822d8da34f52d.pdf">PDF</a>]</li><li>Quaynor, S. D., Stradtman, E. W., Kim, H., Shen, Y., Chorich, L. P., Schreihofer, D. A., &amp; Layman, L. C. (2013). Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor α Variant. <em>New England Journal of Medicine</em>, <em>369</em>(2), 164–171. [DOI:<a href="https://doi.org/10.1056/nejmoa1303611">10.1056/nejmoa1303611</a>]</li><li>Rinaldi, S., Geay, A., Déchaud, H., Biessy, C., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Riboli, E., Toniolo, P., &amp; Kaaks, R. (2002). Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. <em>Cancer Epidemiology and Prevention Biomarkers</em>, <em>11</em>(10), 1065–1071. [<a href="https://scholar.google.com/scholar?cluster=18409886331928026045">Google Scholar</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12376508/">PubMed</a>] [<a href="https://aacrjournals.org/cebp/article/11/10/1065/166164/Validity-of-Free-Testosterone-and-Free-Estradiol">URL</a>]</li><li>Vermeulen, A., Verdonck, L., &amp; Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. <em>The Journal of Clinical Endocrinology &amp; Metabolism</em>, <em>84</em>(10), 3666–3672. [DOI:<a href="https://doi.org/10.1210/jcem.84.10.6079">10.1210/jcem.84.10.6079</a>]</li></ul></div></div><div id="footer"> <span id="footer-subcontainer"> <span id="site-copyright">&copy; 2024 <span translate="no" class="notranslate">Transfeminine Science</span></span> </span></div></div></body></html>